This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Catheters or Catheterization, Peripheral
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

A randomized prospective comparison of two FDA approved intravenous catheters in the emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise to increase intravenous access success rates and decrease blood contamination of the insertion site. This study would analyze these properties in our busy, urban emergency department setting where time and safety of intravenous access are most critical.

Provided treatments

  • Device: Terumo SurFlash Plus catheter
  • Device: BD Insyte Autoguard catheter
Tris trial is registered with FDA with number: NCT02769442. The sponsor of the trial is University of Maryland and it is looking for 600 volunteers for the current phase.
Official trial title:
Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED